Cancer Letters

Cancer Letters

Volume 90, Issue 1, 23 March 1995, Pages 27-33
Cancer Letters

Is episialin/MUC1 involved in breast cancer progression?

https://doi.org/10.1016/0304-3835(94)03674-8Get rights and content

Abstract

Episialin, also designated MUC1, CA 15-3 antigen and PEM, is an established serum marker for breast cancer. Its function and possible involvement in tumor progression has not yet been completely established. The molecule is an extended rod-like molecule protruding high above the cell surface. It is often highly overexpressed in breast cancer relative to normal breast epithelium cells. Overexpression of episialin on cells in vitro reduces cell-cell and cellextracellular matrix adhesion, because the rod-like molecule masks the adhesion receptors. Episialin also exerts its antiadhesion effect in vivo. In certain human tumors, where episialin was present at the basal side of the cell, abnormal contacts between the plasma membrane and the stroma were observed. As a consequence of its anti-adhesion properties, episialin overexpression reduces the sensitivity of the cells for cytotoxic lymphocytes. This might be one of the reasons why episialin transfected cells are more potent to form experimental metastases after i.v. injection into nude mice.

References (22)

  • C.M. Chan et al.

    Monoclonal antibody BrE-3 participation in a multivariate prognostic model for infiltrating ductal carcinoma of the breast

    Breast Cancer Res. Treatment

    (1994)
  • Cited by (0)

    1

    On leave from the Department of Pathology, Ospedale S. Paolo, University of Milan. Italy.

    View full text